COOKEVILLE, Tenn.--(BUSINESS WIRE)--May 15, 2019--

Aphena Pharma Solutions Inc. today announced that it has approved $7 million for company-wide expansion for future growth opportunities to be completed by the end of 2019. Targeted expansion areas include additional manufacturing space, custom blending suites, new liquid blending vessels and an additional high-speed bottling line.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190515005033/en/

From left, Aphena Pharma Solutions COO Bob Scott, CEO Shawn Reilley and Executive VP of Sales and Marketing Eric Allen meet to make plans for a $7 million approved expansion to Aphena’s manufacturing space and equipment. (Photo: Business Wire)

“As Aphena continues our path towards healthcare contract service excellence and innovation, we are committed to investing in our customers’ future and earning our place as their preferred and trusted partner,” said Aphena CEO Shawn Reilley.

The $7 million expansion includes:

  • Two additional large pharmaceutical blending suites with separate air handling systems in the company’s manufacturing facility in Maryland
  • Two “state of the art” tri-mix blending tanks with counter-rotating sweep and high-shear mixing with vacuum to handle small and large batching for specialty creams, gels and topical products
  • A 30,000-square-foot expansion of the Tennessee facility
  • An additional high-speed, fully-automated bottling line with serialization in the company’s Tennessee facility to support both over-the-counter (OTC) and prescription products

“These planned expansions at our Maryland and Tennessee facilities will position Aphena to support significant future growth,” said Aphena COO Bob Scott. “We are committed to investing aggressively as needed to ensure that Aphena remains an industry leader in terms of innovation and turnaround time.”

Aphena Pharma Solutions Inc. is an industry-leading organization providing contract packaging and manufacturing solutions for the pharmaceutical, consumer health and medical device markets. With two separate FDA- and DEA-registered sites in the U.S., Aphena handles solid dose, liquids, gels, creams, ointments, foams, suspensions and lotions.

For more information about Aphena, visit www.AphenaPharma.com or call 1-866-465-4506.

CONTACT: Aphena Pharma Solutions Inc.

Eric Allen, 1-866-465-4506

KEYWORD: UNITED STATES NORTH AMERICA MARYLAND TENNESSEE

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY MEDICAL DEVICES PHARMACEUTICAL MANUFACTURING CHEMICALS/PLASTICS PACKAGING RETAIL COSMETICS

SOURCE: Aphena Pharma Solutions Inc.

Copyright Business Wire 2019.

PUB: 05/15/2019 08:00 AM/DISC: 05/15/2019 08:00 AM

Copyright Business Wire 2019.

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.

PLEASE BE ADVISED: Soon we will no longer integrate with Facebook for story comments. The commenting option is not going away, however, readers will need to register for a FREE site account to continue sharing their thoughts and feedback on stories. If you already have an account (i.e. current subscribers, posting in obituary guestbooks, for submitting community events), you may use that login, otherwise, you will be prompted to create a new account.

Load comments